Evidence is mounting that SARS-CoV-2 uses heparan sulfates during the initial attachment to hosts cells, and this interaction appears to increase the affinity for the critical receptor, ACE
Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA